AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 6,930.80
-16.15 (-0.23%)
At close: Sep 4, 2026
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 173.27 billion as of September 4, 2026. Its market cap has decreased by -23.71% in one year.
Market Cap
173.27B
Enterprise Value
169.90B
Revenue
24.32B
Ranking
n/a
PE Ratio
102.15
Stock Price
6,930.80
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 173.27B, an increase of 11,849.66%. That is a compound annual growth rate of 21.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 173.27B | -23.08% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 501.20B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Caplin Point Laboratories | 213.61B |
| Granules India | 210.03B |
| Jubilant Pharmova | 146.31B |
| Viyash Scientific | 115.84B |
| Procter & Gamble Health | 93.92B |
| Sanofi India | 72.55B |